Develops drugs for treatments of allergic diseases
Apitope has raised €12M across 1 funding round from 1 investor, most recently a Series B round in Sep 2015. Based in Emersons Green, UK; founded 2002; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-09-01 | Series B | €12M |
| Wyvern SEED Fund |
| View deal → |
